BSD Medical Reports Initiation of a Phase III Pancreatic Cancer Study

SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical reports initiation of a randomized, multicenter, Phase III clinical study in Germany using the BSD-2000 Hyperthermia System for the treatment of pancreatic cancer patients.

Feed Date: 
February 21, 2012